medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Number 616

<< Back Next >>

Rev Med Cos Cen 2015; 72 (616)

Uso de drogas antihipertensivas en embarazo y postparto

González CJP, Arguelles AAB, Vargas AC

Language: Spanish
References: 15
Page: 521-525
PDF size: 201.83 Kb.


ABSTRACT

Hypertension is among most common medical disorder in pregnancy, and is reported to complicate 5-10% of pregnancies. These disorders are a major cause of maternal and perinatal mortality and morbidity worldwide. Because of the increasing incidence of hypertension and obesity, the latest pharmacological use and management must be of knowledge, because of the several adverse effects in the pregnancy and perinatal outcomes.


REFERENCES

  1. Bellomo, G., Venanzi, S., Saronio, P., & Verdura, C. (2011). Prognostic significance of serum uric acid in women with gestacional hypertension. Hypertension , 58: 704-708.

  2. Bramham, K., Nelson-Piercy, C., & Cgappell, L. (2014). Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ , 348:g2301.

  3. Bramham, K., Nelson-Piercy, C., Brown, M., & Chappell, L. (2013). Postpartum management of hypertension. BMJ , 346:f894.

  4. Cooper, W., Hernandez, S., Arbogast, P., & Dudley, J. (2006). Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med , 354: 2443-51.

  5. Gabbe, S., Niebyl, J., Simpson, J., Landon, M., & Galan, H. (2012). Obstetrics Normal and problem pregnancies 6th edition. Philadelphia: Elsevier.

  6. Heida, K., Zeeman, G., & Van Veen, T. (2012). Neonatal side effects of maternal labetalol treatment in severe preeclampsia. Early Human Development , 503-507.

  7. Molvi, S., Mir, S., Rana, V., Jabeen, F., & Malik, R. (2012). Role of antihypertensive therapy in mild to moderate pregnancyinduced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa. Arch Gynecol Obstet , 285: 1553- 1562.

  8. Nakhai-Pou, H., Rey, E., & Berard, A. (2009). Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of. Am J Obstet Gynecol , 201:180.e1-8.

  9. Orbach, H., Matok, I., & Gorodischer, R. (2013). Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol , 208:301.e1-6.

  10. Peacock, W., Hilleman, D., Levy, P., Rhoney, D., & Varon, J. (2012). A systematic review of nicardipine vs labetalol for the management of hypertensive crises. The American Journal of Emergency Medicine , 30: 981-993.

  11. Podymow, T., & August, P. (2008). Update on the use of antihypertensive drugs in pregnancy. American Heart Association-Hypertension , 51: 960- 969.

  12. Sibai, B. (2012). Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol , 470-475.

  13. Xie, R., Guo, Y., Krewski, D., & Mattison, D. (2014). Association between labetalol use for hypertension in pregnancy and adverse infant outcomes. European Journal of Obstetrics and Gynecology and Reproductive Biology , 124-128.

  14. Xie, R., Guo, Y., Krewski, D., & Mattison, D. (2013). Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population. European Journal of Obstetrics & Gynecology and Reproductive Biology , 281-285.

  15. Yakoob, M., Bateman, B., Ho, E., Hernandez, S., Franklin, J., & Goodman, J. (2013). The risk of congenital malformations associated with exposure to beta-blockers early in pregnancy: a meta-analysis. Hypertension , 62: 375-381.




2020     |     www.medigraphic.com